Related Experiment Video
Updated: Jan 6, 2026

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.5K
Adjuvant radiation for vulvar carcinoma: improved local control
1Department of Radiation Oncology, Magee Women's Hospital, University of Pittsburgh Medical School, PA 15213, USA.
Summary
Adjuvant vulvar radiation significantly reduced local recurrence in advanced vulva carcinoma patients. This therapy may improve survival, as local recurrence after surgery has poor outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Gynecologic Oncology
Background:
- Local recurrence is a significant challenge in advanced vulva carcinoma post-surgery.
- High-risk patients require effective strategies to improve local control and overall survival.
Purpose of the Study:
- To assess the impact of adjuvant vulvar radiation on local control in high-risk vulva carcinoma patients.
- To determine the effect of local recurrence on overall survival in this patient cohort.
Main Methods:
- Retrospective study of 62 patients with invasive vulva carcinoma (1980-1994).
- Comparison of 31 patients treated with adjuvant radiation therapy versus 31 observed patients.
- Kaplan-Meier and Cox regression analyses used to evaluate local recurrence and survival outcomes.
Main Results:
- Adjuvant radiation therapy decreased local recurrence rates from 58% to 16% (p=0.036, p=0.0048).
- Adjuvant radiation and surgical margins were significant predictors of local control.
- Local recurrence was a significant predictor of death (risk ratio 3.54), with 2-year survival at 25%.
Conclusions:
- Adjuvant vulvar radiation therapy significantly reduces local recurrence rates in high-risk vulva carcinoma patients.
- The therapy may improve overall survival, particularly in subgroups with positive margins.
- Adjuvant radiation should be considered for high-risk patients post-primary surgery due to poor salvage rates after recurrence.
Related Concept Videos
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

